COH29
Product Specifications
CAS Number
1190932-38-7
Target
DNA/RNA Synthesis
Related Pathways
DNA Damage/DNA Repair, Cell Cycle/Checkpoint
Purity
0.9892
Bioactivity
COH29 (RNR Inhibitor COH29) is an orally available, aromatically substituted thiazole and human ribonucleotide reductase (RNR) inhibitor with potential antineoplastic activity. COH29 binds to the ligand-binding pocket of the RNR M2 subunit (hRRM2) near the C-terminal tail, decreasing the pool of deoxyribonucleotide triphosphates needed for DNA synthesis, leading to cell cycle arrest and growth inhibition. It may also inhibit the nuclear enzyme poly (ADP-ribose) polymerase (PARP) 1, preventing DNA repair, causing accumulation of DNA breaks, and inducing apoptosis.
Smiles
Oc1ccc(cc1O)C(=O)Nc1nc(c(s1)-c1ccccc1)-c1ccc(O)c(O)c1
Molecular Formula
C22H16N2O5S
Molecular Weight
420.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036914-ML405 100 µL
IGFBP4, ID (IGFBP4, IBP4, Insulin-like growth factor-binding protein 4) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
GTR15364819 1 Vial
Lentiviral human OR4N5 sgRNA gene knockout kit - Lentiviral human OR4N5 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 
orb3011183-01 20 µg
Recombinant Human Lymphotoxin-beta (TNFC), partial
Sign In for Pricing
View Details orb3011183-02 100 µg
Recombinant Human Lymphotoxin-beta (TNFC), partial
Sign In for Pricing
View Details orb3011183-03 1 mg
Recombinant Human Lymphotoxin-beta (TNFC), partial
Sign In for Pricing
View Details